Proto Labs (NYSE:PRLB) Issues Q3 2025 Earnings Guidance

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Proto Labs (NYSE:PRLB - Get Free Report) issued an update on its third quarter 2025 earnings guidance on Thursday morning. The company provided earnings per share guidance of 0.350-0.430 for the period, compared to the consensus earnings per share estimate of 0.371. The company issued revenue guidance of $130.0 million-$138.0 million, compared to the consensus revenue estimate of $129.7 million.

Proto Labs Trading Up 0.3%

NYSE:PRLB traded up $0.15 during trading hours on Friday, reaching $43.27. 360,735 shares of the company traded hands, compared to its average volume of 171,804. The business's 50-day moving average price is $39.29 and its two-hundred day moving average price is $38.59. Proto Labs has a 1 year low of $25.75 and a 1 year high of $46.73. The stock has a market capitalization of $1.03 billion, a P/E ratio of 72.12 and a beta of 1.33.

Proto Labs (NYSE:PRLB - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The industrial products company reported $0.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.33 by $0.08. The firm had revenue of $135.06 million during the quarter, compared to analyst estimates of $128.05 million. Proto Labs had a return on equity of 2.22% and a net margin of 2.91%. Proto Labs's quarterly revenue was up 7.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.38 EPS. As a group, equities analysts anticipate that Proto Labs will post 0.81 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the stock. Craig Hallum upgraded shares of Proto Labs from a "hold" rating to a "buy" rating and set a $54.00 price target on the stock in a report on Friday. Wall Street Zen upgraded Proto Labs from a "buy" rating to a "strong-buy" rating in a research note on Saturday. Finally, Cantor Fitzgerald lifted their target price on Proto Labs from $50.00 to $51.00 and gave the stock an "overweight" rating in a report on Friday.

Institutional Trading of Proto Labs

A number of large investors have recently made changes to their positions in the stock. NewEdge Advisors LLC lifted its position in Proto Labs by 7,380.0% during the first quarter. NewEdge Advisors LLC now owns 748 shares of the industrial products company's stock valued at $26,000 after purchasing an additional 738 shares during the period. AQR Capital Management LLC raised its stake in Proto Labs by 3.3% during the 1st quarter. AQR Capital Management LLC now owns 63,871 shares of the industrial products company's stock valued at $2,238,000 after buying an additional 2,040 shares during the last quarter. Finally, Royal Bank of Canada lifted its holdings in shares of Proto Labs by 51.3% during the 1st quarter. Royal Bank of Canada now owns 6,510 shares of the industrial products company's stock valued at $228,000 after buying an additional 2,207 shares during the period. 84.54% of the stock is currently owned by institutional investors.

Proto Labs Company Profile

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.